SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Exacctnt who wrote (23061)9/24/1997 6:27:00 PM
From: Knighty Tin   of 132070
 
Bob, Gene is the Rodney Dangerfield of the genomics game. For some reason, when they have good or great news, nobody cares. HGSI or INCY come out with similar news and their stocks skyrocket. Not that I'm complaining all that much. I made a ton of sheckels on Incyte and Human Genome. But I can't quite understand Gene's lack of support.

The SGP news was excellent, though most of the money was a bet on the come line. The drugs have to work before Gene gets the bulk of it. Still, GENE has done great science for awhile and this is a another major doper acknowledging the fact. It think this stock should be selling in the high teens or low twenties given its pipeline of discoveries and long term potential.

I like Medarex. It is cheap. I don't quite get this one and CEGE, either. CEGE is zipping up and MEDX is languishing. A few months back, the opposite was true. But two excellent little cos in the gene modification area. MEDX is probably the better buy at these prices.

Neurex's labeling information wasn't perfect, but it wasn't bad. I like the idea that there is going to be some nice cash flow coming in in the near future to fund the snail poison medicine for pain and the rest of the research. The stock ticked up a bit, but it is still dirt cheap, IMHO. MB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News